Zohreh Amoozgar
Visiting Scientist Harvard Medical School
I am a translational immuno-oncologist (Pharm.D., Ph.D.). I have worked collaboratively within multiple disciplines and have significant experience with (i) tumor immunology, (ii) advanced drug delivery formulations, and (iii) translational medicine.
Seminars
Tuesday 17th February 2026
Moving Towards Standardized Preclinical & Translational Study Methodology to Advance the Next Generation of Glioblastoma Models
2:00 pm
- Join this workshop to collectively work towards standardized and effective preclinical GBM models to ensure convincing preclinical data is produced to reduce regulatory bottlenecks
- Acknowledging the current limitations with preclinical and translational models that mimic the human immune system for immunotherapy research in Glioblastoma
- Discussing strategies to overcome the challenges of in preserving cellular and mutational diversities in primary tumours to overcome the prolonged development time
- Advancing the use of K9 models as an improved model for paediatric Glioblastomas
- Exploring patient-derived glioblastoma organoid models to recapitulate the heterogeneity of glioblastomas to overcome the complexities of developing effective therapeutic strategies
- Evaluating the practical applications of glioblastoma organoids for rapidly testing patient-specific treatment strategies involving correlating mutation profiles with drug responses to advance personalized therapies
